Abstract
The COVID-19 pandemic has had significant implications for patients with malignant diseases, revealing complex interactions between viral infection and cancer. This review explores the association of COVID-19 infection with various malignant diseases, including hematological malignancies and solid tumors. Potential mechanisms underlying this association include immune dysregulation, chronic inflammation, and alterations in the tumor microenvironment. Additionally, the pandemic has disrupted cancer care, leading to delays in diagnosis and treatment while increasing the vulnerability of cancer patients to severe COVID-19 outcomes. The review emphasizes the need for enhanced cancer care protocols, ongoing research into the long-term effects of COVID-19 on cancer progression, and support for the psychosocial needs of patients. By addressing these challenges, the healthcare community can improve patient outcomes and develop effective strategies for managing malignant diseases in the context of a global pandemic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
